Publication:
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.

Loading...
Thumbnail Image

Date

2020-06-17

Authors

Montero-Vilchez, Trinidad
Martinez-Lopez, Antonio
Salvador-Rodriguez, Luis
Molina-Leyva, Alejandro
Arias-Santiago, Salvador

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Hindawi Limited
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The recent coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) virus, has spread all over the world. As of April 21, 2020, there were 2 478 948 cases of infection, of which 652 046 have resolved, and 170 399 people have died in 185 different countries. The elderly and people with underlying conditions such as cardiovascular disease, obesity, diabetes or cancer are at the highest risk of infection and prone to serious outcomes.

Description

MeSH Terms

COVID-19
Hidradenitis Suppurativa
Humans
SARS-CoV-2

DeCS Terms

Hidradenitis supurativa
SARS-CoV-2
Humanos

CIE Terms

Keywords

Hidradenitis Suppurativa, Aged, Cardiovascular Diseases, Pandemics, Death, Obesity

Citation

Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e13875.